Manifold Secures $8.0M

Manifold has secured $8.0 million in a recent funding round.

The company operates as an AI platform specifically designed for the life sciences sector, with a mission to accelerate the development and delivery of life-changing medicines to patients.

Manifold's suite of products is engineered to streamline critical workflows across various stages of drug development.

This includes accelerating processes from initial target identification and clinical development through to market access and the application of precision medicine in clinical settings.

A key aspect of its platform is maintaining the stringent governance required within the life sciences industry.

This new capital infusion is poised to significantly bolster Manifold's capabilities.

The funds will be strategically deployed to further enhance its AI platform, scale its operational infrastructure, and expand its market presence globally.

Manifold currently serves tens of thousands of users across hundreds of organizations worldwide, including global companies and premier research institutions that rely on its technology to operate more rapidly and effectively.

The funding round saw participation from a group of prominent investors, including Reach Capital, TQ Ventures, Calibrate Ventures, SilverArc Capital, and Industry Ventures.

This investment underscores confidence in Manifold's technology and its impact on accelerating innovation in life sciences.

Looking ahead, Manifold plans to continue its trajectory of growth, focusing on deepening its platform's capabilities and extending its reach to empower more organizations in bringing vital medicines to patients faster.